Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Medical College of Wisconsin
Memorial Sloan Kettering Cancer Center
University of Alabama at Birmingham
Thomas Jefferson University
Thomas Jefferson University
Northside Hospital, Inc.
Brown University
GWT-TUD GmbH
University of Arkansas
Mayo Clinic
Eastern Cooperative Oncology Group
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
University of Arkansas
City of Hope Medical Center
Fred Hutchinson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
Janssen Scientific Affairs, LLC
Thomas Jefferson University
European Myeloma Network B.V.
Universitätsklinikum Hamburg-Eppendorf
Amsterdam UMC, location VUmc
Fred Hutchinson Cancer Center
University of Turin, Italy
University of Leeds
University of Leeds
University of Turin, Italy
European Myeloma Network B.V.
University of Leeds
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Oncotherapeutics
University of Nebraska
Ohio State University Comprehensive Cancer Center
University of Birmingham
Masonic Cancer Center, University of Minnesota
European Myeloma Network B.V.
Canadian Cancer Trials Group
Massachusetts General Hospital
Canadian Myeloma Research Group
Eastern Cooperative Oncology Group
Dong-A University Hospital
Northside Hospital, Inc.